312 related articles for article (PubMed ID: 33426601)
21. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
22. Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach.
Bu R; Siraj AK; Parvathareddy SK; Iqbal K; Azam S; Qadri Z; Al-Rasheed M; Haqawi W; Diaz M; Alobaisi K; Annaiyappanaidu P; Siraj N; AlHusaini H; Alomar O; Al-Badawi IA; Al-Dayel F; Al-Kuraya KS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293153
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Latham A; Srinivasan P; Kemel Y; Shia J; Bandlamudi C; Mandelker D; Middha S; Hechtman J; Zehir A; Dubard-Gault M; Tran C; Stewart C; Sheehan M; Penson A; DeLair D; Yaeger R; Vijai J; Mukherjee S; Galle J; Dickson MA; Janjigian Y; O'Reilly EM; Segal N; Saltz LB; Reidy-Lagunes D; Varghese AM; Bajorin D; Carlo MI; Cadoo K; Walsh MF; Weiser M; Aguilar JG; Klimstra DS; Diaz LA; Baselga J; Zhang L; Ladanyi M; Hyman DM; Solit DB; Robson ME; Taylor BS; Offit K; Berger MF; Stadler ZK
J Clin Oncol; 2019 Feb; 37(4):286-295. PubMed ID: 30376427
[TBL] [Abstract][Full Text] [Related]
24. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.
Toon CW; Walsh MD; Chou A; Capper D; Clarkson A; Sioson L; Clarke S; Mead S; Walters RJ; Clendenning M; Rosty C; Young JP; Win AK; Hopper JL; Crook A; von Deimling A; Jenkins MA; Buchanan DD; Gill AJ
Am J Surg Pathol; 2013 Oct; 37(10):1592-602. PubMed ID: 23797718
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
26. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers.
van der Werf-'t Lam AS; Terlouw D; Tops CM; van Kan MS; van Hest LP; Gille HJP; Duijkers FAM; Wagner A; Eikenboom EL; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker FE; Gomez Garcia EB; de Wind N; van Wezel JT; Morreau H; Suerink M; Nielsen M
Mod Pathol; 2023 Sep; 36(9):100240. PubMed ID: 37307877
[TBL] [Abstract][Full Text] [Related]
27. Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.
Dempsey KM; Broaddus R; You YN; Noblin SJ; Mork M; Fellman B; Urbauer D; Daniels M; Lu K
Genet Med; 2015 Jun; 17(6):476-84. PubMed ID: 25341111
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
[TBL] [Abstract][Full Text] [Related]
29. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
[TBL] [Abstract][Full Text] [Related]
30. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
[TBL] [Abstract][Full Text] [Related]
31. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
32. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis.
Abu-Ghazaleh N; Kaushik V; Gorelik A; Jenkins M; Macrae F
Genet Med; 2022 May; 24(5):971-985. PubMed ID: 35177335
[TBL] [Abstract][Full Text] [Related]
33. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
[TBL] [Abstract][Full Text] [Related]
34. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
35. Lynch or not Lynch? Is that always a question?
Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
[TBL] [Abstract][Full Text] [Related]
36. Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test.
Alqahtani M; Grieu F; Carrello A; Amanuel B; Mashour M; Alattas R; Alsaleh K; Alsheikh A; Alqahtani S; Iacopetta B
Asian Pac J Cancer Prev; 2016; 17(4):1917-23. PubMed ID: 27221876
[TBL] [Abstract][Full Text] [Related]
37. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
38. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
39. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.
Gausachs M; Mur P; Corral J; Pineda M; González S; Benito L; Menéndez M; Espinàs JA; Brunet J; Iniesta MD; Gruber SB; Lázaro C; Blanco I; Capellá G
Eur J Hum Genet; 2012 Jul; 20(7):762-8. PubMed ID: 22274583
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
